Home›Companies›Healthcare›TECLens

TECLens, Inc.

Develops a vision correction device for people with refractive errors.

Updated Nov 10, 2026·Latest SEC filing Jul 24, 2026·Suggest an edit

About TECLens

TECLens is a private company based in Stamford, Connecticut, incorporated in 2024 in Delaware. It has reported $15,865,282 raised in four offerings on Form D since June 2017. Its chief executive is Madhu Ayyagari.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jul 9, 2026Jul 24, 2026$5,230,000of $10.2M target6$871KDebt, Options, Securities on exerciseRule 506(b)Form D ↗
May 30, 2024Jun 13, 2024amended Mar 13, 2025$9,278,350fully sold4$2.3MEquityRule 506(b)Form D/A ↗1 earlier filing
Feb 1, 2019Feb 7, 2019$200,000of $1.5M target1$200KEquityRule 506(b)Form D ↗
May 22, 2017Jun 5, 2017$1,156,932of $4.0M target3$385KEquityRule 506(b)Form D ↗
Total, four offerings$15,865,282

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on TECLens's Form D filed Jul 24, 2026.

Earlier filings also listed Thomas Dunlap (chief executive officer and director, last listed Mar 2025).

Sources

  1. SECTECLens, Inc. Form D, filed Jun 13, 2024
  2. SECTECLens, Inc. filing history
  3. CompanyTECLens leadership